塞拉利昂喘患病率的性别差异
1Institute for Development, Freetown, Western Area, Sierra Leone. augustusosborne2@gmail.com.
BMC pulmonary medicine
|October 9, 2025
概括
塞拉利昂的喘患病率显示,与男性相比,女性的患病率持续较高,这突出了基于性别的显著差异. 解决这些不平等问题需要有针对性的公共卫生干预措施和性别敏感的战略,以有效控制喘.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 全球健康 全球健康
背景情况:
- 喘是一个重大的全球公共卫生挑战,在人口统计学中患病率各不相同.
- 塞拉利昂由于医疗保健基础设施有限,在控制喘方面面临着独特的挑战.
- 现有的全球数据表明喘的性别差异,但它们在塞拉利昂的具体影响仍未得到充分研究.
研究的目的:
- 估计塞拉利昂2000年至2019年的年龄标准化喘患病率.
- 分析随着时间的推移喘患病率的趋势.
- 调查和量化塞拉利昂喘发病率中的基于性别的不平等.
主要方法:
- 利用世界卫生组织 (WHO) 的股权数据库进行分析.
- 对喘患病率进行了年龄标准化的估计.
- 进行了按性别分类的分析和计算的不平等措施 (绝对差异,患病率,人口归因分数,人口归因风险).
主要成果:
- 2000年至2019年,塞拉利昂的年龄标准化喘患病率在每10万人口中波动在2,682.7至2,855.5之间.
- 在所有研究年中,女性的喘患病率始终高于男性.
- 2019年,女性患病率为每10万人中3,104.7人,而男性为每10万人中2,427.8人,这表明了显著的性别差异.
结论:
- 喘在塞拉利昂造成了巨大的负担,女性受影响不成比例.
- 这些发现强调了需要采取干预措施,解决导致基于性别的喘不平等的生物学,行为和环境因素.
- 优先考虑性别分类监测和实施性别敏感策略对于减少喘患病率和改善塞拉利昂的健康公平至关重要.
相关概念视频
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Other Pulmonary Disorders
1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K


